Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-050631

Chief Executive Officer acquired 8,730 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Schenkein David P Chief Executive Officer 2018-09-10 Option exercise +8,730 $31.64 $276,217 83,849 D
Derivatives
Schenkein David P Chief Executive Officer 2018-09-10 Option exercise · Stock option (right to buy) −8,730 137,471 D
Loading xslF345X03/doc4.xml…